Clinical Trial Calendar

Announced DateCompany NameTickerEventIndicationPeriodOutcome
11/13/2014Argos Therapeutics, Inc. ARGS Report phase 2b data of AGS-004 HIV Late 2014
11/05/2014ChemoCentryx Inc. CCXI 52-week data from phase II study of CCX140 Diabetic nephropathy Late 2014 Primary Endpoint achieved; statistically significant reduction in urinary protein over 52 weeks
11/04/2014Achillion Pharmaceuticals Inc. ACHN Top line results from phase I trial of ACH-3422 Hepatitis C Late Q4 2014
11/10/2014Auspex Pharmaceuticals, Inc. ASPX Top line data from phase III study of SD-809 Chorea associated with Huntington's disease Dec 2014 Positive results reported on Dec.16, 2014
11/10/2014Omeros Corp. OMER Preliminary results from phase II trial of OMS721 Thrombotic microangiopathies Dec 2014
11/10/2014Xencor Inc XNCR Top-line data from phase IIa trial of XmAb5871 Moderate-to-severe rheumatoid arthritis Dec 2014
11/12/2014Kamada Ltd KMDA Phase III trial data of KamRAB Post-exposure prophylactic treatment of rabies Dec 2014
11/06/2014Infinity Pharmaceuticals Inc. INFI Phase II study data of Duvelisib, dubbed ASPIRA, Moderate-to-severe rheumatoid arthritis, Dec 2014
11/10/2014Aratana Therapeutics Inc PETX Topline data pivotal field effectiveness study of AT-001 Pain in dogs with osteoarthritis. Dec 2014 Positive results announced on Dec.18, 2014